Abstract
Cardiovascular diseases (CVD) are the leading mortality cause in China due to rapidly aging population and unfavorable lifestyle change caused by urbanization. Elevated level of low-density lipoprotein cholesterol (LDL-C) is one of the key modifiable CVD risk factors. This study reviewed publications on epidemiology, disease burden, and treatment landscape related to dyslipidemia in China and compared findings with other advanced countries.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
